FRED — the Fore Research, Evidence & Development hub

A shared, multi-user board where the team turns a finding into a structured study — goal, evidence, strategy — and moves it toward a decision. Supporting Fore Biotherapeutics’ targeted-therapy programs for the hardest-to-treat cancers.

Precision oncology BRAF · plixorafenib Agentic in-silico engine Live multi-user

🔒 Enter the board

Team access only. Enter your work email and the collaboration keyword.

Work email Access keyword

Don't have it? Ask Hugh (hdonatello@Fore.bio).

How the board works

Capture → evidence → strategy → paper

💡

Capture an idea

One line in the idea bar, a quick question/hypothesis, or a full study — whatever you've got.

📎

Attach the evidence

Link the reports, datasets, and 3D structures that back the idea so reviewers can trace the claim.

🔗

Link related studies

Connect work across lanes so threads build instead of scattering.

💬

Discuss & promote

Comment per-study, then promote a question into a full study when it's ready for a paper.

Four collaborator lanes

Four collaborator lanes, one shared board

🧮 Computational / structureTarget modeling, structure analysis, in-silico screening and prioritization.
Lane: Computational
⚗️ Medicinal chemistrySAR, selectivity, and property optimization of lead series.
Lane: Chemistry
🧬 Target & translational biologyMechanism, biomarkers, resistance, and responder hypotheses.
Lane: Biology
🏥 Clinical / RWETrial evidence, biomarker prevalence, safety and competitive landscape.
Lane: Clinical